Patent · US Active

Cancer diagnostics using non-coding transcripts

US10513737B2 · kind B2 · utility

6Cited by
86References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2012
Grant dateDec 24, 2019
Priority date
Expiry dateApr 10, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Disclosed herein, in certain instances, are methods for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods for determining the treatment modality of a cancer in a subject. The methods comprise expression-based analysis of non-coding targets and coding targets. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.